AstraZeneca sticks to 2020 outlook, boosted by drug stockpiling

AstraZeneca topped analysts' estimates for quarterly profit and reiterated its targets for the year on Wednesday, as the British drugmaker benefited from higher demand for some of its medicines during the coronavirus pandemic.